Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

ENT endoscopy Market by Product Type (Rigid Endoscopes, Flexible Endoscopes, Hearing Screening Devices) and by End User (Hospitals, Ambulatory Settings, ENT Clinics): Global Opportunity Analysis and Industry Forecast, 2023-2032

A12588

Pages: NA

Charts: NA

Tables: NA

ENT endoscopy is a less invasive medical procedure that diagnoses treats and prevents concerns associated with the ear, nose, and throat. These devices are placed in the body through natural openings such as the mouth and anus or incisions to study interior hollow organs of the body in the endoscopy procedure. A camera or light source is attached to the endoscopy devices at the top of endoscopes that assist endoscopists in analyzing internal organs of interest. Endoscopy is used to investigate symptoms in the ENT system, difficulty in swallowing, and internal bleeding.

COVID-19 Impact analysis

COVID-19 is an infectious disease that originated in Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome corona virus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.

There has been an increase in the demand for medical supplies to take care of infected population. Respiratory support devices such as atomizers, life-support machines, oxygen generators, and monitors are among the majorly used medical devices in primary clinical treatment. Moreover, COVID-19 has led to a huge surge in demand for medical supplies such as personal protective equipment including masks, gloves, and protective eyeglasses. There is an increase in the need for medical supplies, both from healthcare professionals and civil population for precautionary measures, owing to the rise in number of COVID-19 cases worldwide. Manufacturers of these products have a chance to capitalize this increased demand for medical supplies to ensure adequate and continuous supply of personal protective equipment in the market. Therefore, COVID 19 is expected to have a significant impact on the ENT endoscopy market.

Top Impacting Factors

  • Increase in cases of ENT diseases, rise in demand for endoscopy devices in diagnostic and therapeutic procedures, surge in geriatric populations, rise in demand for minimally invasive procedure & advanced treatments are the factors that drive the growth of the ENT endoscopy market
  • In addition, increase in healthcare expenditure; availability of skilled professionals; collaborations & partnerships between key players to facilitate ENT endoscopy device development; rise in R&D activities to launch of novel developed devices in the market; and technological advancements are some factors, which boost the market growth for ENT endoscopy.
  • However, product recalls, lack of knowledge for proper handling of the device as well as associated complications and high production cost hinder the market growth.

Market Trends

New product launches to flourish the market

In March 2018, Olympus Corporation launched “ENF-VT3”, which is a flexible NBI (Narrowband imaging) based device, as the most notable and prominent developments in the ENT market.

In May 2021, the Madhya Pradesh government declared about the launch of the "nasal endoscopy" campaign due to rising incidences of mucormycosis in COVID-19 patients. The main objective of this campaign was the early detection and treatment of mucormycosis, a rare but dangerous fungal infection.

Key Benefits of the Report

  • This study presents the analytical depiction of the ENT endoscopy industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the ENT endoscopy market share.
  • The current market is quantitatively analyzed to highlight the ENT endoscopy market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed ENT endoscopy market analysis based on competitive intensity and how the competition will take shape in coming years

Questions answered in the ENT endoscopy Report

  • Which are the leading players active in the ENT endoscopy market?
  • What are the current trends that will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities of the market?
  • What future projections would help in taking further strategic steps?
  • What is "ENT endoscopy"?
  • What is "ENT endoscopy” Market prediction in the future?
  • Who are the leading global players in the "ENT endoscopy” Market?
  • What are the current trends and predicted trends?
  • What are the key benefits of the “ENT endoscopy “Market report?

 Key Market Segments

  • By Product Type
    • Rigid Endoscopes
    • Flexible Endoscopes
    • Hearing Screening Devices
  • By End User
    • Hospitals
    • Ambulatory Settings
    • ENT Clinics
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • Italy
      • Spain
      • UK
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • South Africa
      • Saudi Arabia
      • Rest of LAMEA

 
Key Market Players

  • HOYA
  • Stryker
  • Johnson and Johnson
  • Aohua
  • Fujifilm
  • EndoChoice
  • Karl Storz
  • Olympus
  • Medtronic Plc.
  • Richard Wolf

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: ENT ENDOSCOPY MARKET, BY PRODUCT TYPE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Product Type

    • 4.2. Rigid Endoscopes

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Flexible Endoscopes

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Hearing Screening Devices

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

  • CHAPTER 5: ENT ENDOSCOPY MARKET, BY END USER

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By End User

    • 5.2. Hospitals

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Ambulatory Settings

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. ENT Clinics

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

  • CHAPTER 6: ENT ENDOSCOPY MARKET, BY REGION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Region

    • 6.2. North America

      • 6.2.1. Key Market Trends and Opportunities

      • 6.2.2. Market Size and Forecast, By Product Type

      • 6.2.3. Market Size and Forecast, By End User

      • 6.2.4. Market Size and Forecast, By Country

      • 6.2.5. U.S. Ent Endoscopy Market

        • 6.2.5.1. Market Size and Forecast, By Product Type
        • 6.2.5.2. Market Size and Forecast, By End User

      • 6.2.6. Canada Ent Endoscopy Market

        • 6.2.6.1. Market Size and Forecast, By Product Type
        • 6.2.6.2. Market Size and Forecast, By End User

      • 6.2.7. Mexico Ent Endoscopy Market

        • 6.2.7.1. Market Size and Forecast, By Product Type
        • 6.2.7.2. Market Size and Forecast, By End User

    • 6.3. Europe

      • 6.3.1. Key Market Trends and Opportunities

      • 6.3.2. Market Size and Forecast, By Product Type

      • 6.3.3. Market Size and Forecast, By End User

      • 6.3.4. Market Size and Forecast, By Country

      • 6.3.5. France Ent Endoscopy Market

        • 6.3.5.1. Market Size and Forecast, By Product Type
        • 6.3.5.2. Market Size and Forecast, By End User

      • 6.3.6. Germany Ent Endoscopy Market

        • 6.3.6.1. Market Size and Forecast, By Product Type
        • 6.3.6.2. Market Size and Forecast, By End User

      • 6.3.7. Italy Ent Endoscopy Market

        • 6.3.7.1. Market Size and Forecast, By Product Type
        • 6.3.7.2. Market Size and Forecast, By End User

      • 6.3.8. Spain Ent Endoscopy Market

        • 6.3.8.1. Market Size and Forecast, By Product Type
        • 6.3.8.2. Market Size and Forecast, By End User

      • 6.3.9. UK Ent Endoscopy Market

        • 6.3.9.1. Market Size and Forecast, By Product Type
        • 6.3.9.2. Market Size and Forecast, By End User

      • 6.3.10. Russia Ent Endoscopy Market

        • 6.3.10.1. Market Size and Forecast, By Product Type
        • 6.3.10.2. Market Size and Forecast, By End User

      • 6.3.11. Rest Of Europe Ent Endoscopy Market

        • 6.3.11.1. Market Size and Forecast, By Product Type
        • 6.3.11.2. Market Size and Forecast, By End User

    • 6.4. Asia-Pacific

      • 6.4.1. Key Market Trends and Opportunities

      • 6.4.2. Market Size and Forecast, By Product Type

      • 6.4.3. Market Size and Forecast, By End User

      • 6.4.4. Market Size and Forecast, By Country

      • 6.4.5. China Ent Endoscopy Market

        • 6.4.5.1. Market Size and Forecast, By Product Type
        • 6.4.5.2. Market Size and Forecast, By End User

      • 6.4.6. Japan Ent Endoscopy Market

        • 6.4.6.1. Market Size and Forecast, By Product Type
        • 6.4.6.2. Market Size and Forecast, By End User

      • 6.4.7. India Ent Endoscopy Market

        • 6.4.7.1. Market Size and Forecast, By Product Type
        • 6.4.7.2. Market Size and Forecast, By End User

      • 6.4.8. South Korea Ent Endoscopy Market

        • 6.4.8.1. Market Size and Forecast, By Product Type
        • 6.4.8.2. Market Size and Forecast, By End User

      • 6.4.9. Australia Ent Endoscopy Market

        • 6.4.9.1. Market Size and Forecast, By Product Type
        • 6.4.9.2. Market Size and Forecast, By End User

      • 6.4.10. Thailand Ent Endoscopy Market

        • 6.4.10.1. Market Size and Forecast, By Product Type
        • 6.4.10.2. Market Size and Forecast, By End User

      • 6.4.11. Malaysia Ent Endoscopy Market

        • 6.4.11.1. Market Size and Forecast, By Product Type
        • 6.4.11.2. Market Size and Forecast, By End User

      • 6.4.12. Indonesia Ent Endoscopy Market

        • 6.4.12.1. Market Size and Forecast, By Product Type
        • 6.4.12.2. Market Size and Forecast, By End User

      • 6.4.13. Rest of Asia Pacific Ent Endoscopy Market

        • 6.4.13.1. Market Size and Forecast, By Product Type
        • 6.4.13.2. Market Size and Forecast, By End User

    • 6.5. LAMEA

      • 6.5.1. Key Market Trends and Opportunities

      • 6.5.2. Market Size and Forecast, By Product Type

      • 6.5.3. Market Size and Forecast, By End User

      • 6.5.4. Market Size and Forecast, By Country

      • 6.5.5. Brazil Ent Endoscopy Market

        • 6.5.5.1. Market Size and Forecast, By Product Type
        • 6.5.5.2. Market Size and Forecast, By End User

      • 6.5.6. South Africa Ent Endoscopy Market

        • 6.5.6.1. Market Size and Forecast, By Product Type
        • 6.5.6.2. Market Size and Forecast, By End User

      • 6.5.7. Saudi Arabia Ent Endoscopy Market

        • 6.5.7.1. Market Size and Forecast, By Product Type
        • 6.5.7.2. Market Size and Forecast, By End User

      • 6.5.8. UAE Ent Endoscopy Market

        • 6.5.8.1. Market Size and Forecast, By Product Type
        • 6.5.8.2. Market Size and Forecast, By End User

      • 6.5.9. Argentina Ent Endoscopy Market

        • 6.5.9.1. Market Size and Forecast, By Product Type
        • 6.5.9.2. Market Size and Forecast, By End User

      • 6.5.10. Rest of LAMEA Ent Endoscopy Market

        • 6.5.10.1. Market Size and Forecast, By Product Type
        • 6.5.10.2. Market Size and Forecast, By End User

  • CHAPTER 7: COMPETITIVE LANDSCAPE

    • 7.1. Introduction

    • 7.2. Top Winning Strategies

    • 7.3. Product Mapping Of Top 10 Player

    • 7.4. Competitive Dashboard

    • 7.5. Competitive Heatmap

    • 7.6. Top Player Positioning, 2024

  • CHAPTER 8: COMPANY PROFILES

    • 8.1. Olympus

      • 8.1.1. Company Overview

      • 8.1.2. Key Executives

      • 8.1.3. Company Snapshot

      • 8.1.4. Operating Business Segments

      • 8.1.5. Product Portfolio

      • 8.1.6. Business Performance

      • 8.1.7. Key Strategic Moves and Developments

    • 8.2. Fujifilm

      • 8.2.1. Company Overview

      • 8.2.2. Key Executives

      • 8.2.3. Company Snapshot

      • 8.2.4. Operating Business Segments

      • 8.2.5. Product Portfolio

      • 8.2.6. Business Performance

      • 8.2.7. Key Strategic Moves and Developments

    • 8.3. HOYA

      • 8.3.1. Company Overview

      • 8.3.2. Key Executives

      • 8.3.3. Company Snapshot

      • 8.3.4. Operating Business Segments

      • 8.3.5. Product Portfolio

      • 8.3.6. Business Performance

      • 8.3.7. Key Strategic Moves and Developments

    • 8.4. Karl Storz

      • 8.4.1. Company Overview

      • 8.4.2. Key Executives

      • 8.4.3. Company Snapshot

      • 8.4.4. Operating Business Segments

      • 8.4.5. Product Portfolio

      • 8.4.6. Business Performance

      • 8.4.7. Key Strategic Moves and Developments

    • 8.5. Stryker

      • 8.5.1. Company Overview

      • 8.5.2. Key Executives

      • 8.5.3. Company Snapshot

      • 8.5.4. Operating Business Segments

      • 8.5.5. Product Portfolio

      • 8.5.6. Business Performance

      • 8.5.7. Key Strategic Moves and Developments

    • 8.6. EndoChoice

      • 8.6.1. Company Overview

      • 8.6.2. Key Executives

      • 8.6.3. Company Snapshot

      • 8.6.4. Operating Business Segments

      • 8.6.5. Product Portfolio

      • 8.6.6. Business Performance

      • 8.6.7. Key Strategic Moves and Developments

    • 8.7. Richard Wolf

      • 8.7.1. Company Overview

      • 8.7.2. Key Executives

      • 8.7.3. Company Snapshot

      • 8.7.4. Operating Business Segments

      • 8.7.5. Product Portfolio

      • 8.7.6. Business Performance

      • 8.7.7. Key Strategic Moves and Developments

    • 8.8. Aohua

      • 8.8.1. Company Overview

      • 8.8.2. Key Executives

      • 8.8.3. Company Snapshot

      • 8.8.4. Operating Business Segments

      • 8.8.5. Product Portfolio

      • 8.8.6. Business Performance

      • 8.8.7. Key Strategic Moves and Developments

    • 8.9. Johnson And Johnson

      • 8.9.1. Company Overview

      • 8.9.2. Key Executives

      • 8.9.3. Company Snapshot

      • 8.9.4. Operating Business Segments

      • 8.9.5. Product Portfolio

      • 8.9.6. Business Performance

      • 8.9.7. Key Strategic Moves and Developments

    • 8.10. Medtronic Plc.

      • 8.10.1. Company Overview

      • 8.10.2. Key Executives

      • 8.10.3. Company Snapshot

      • 8.10.4. Operating Business Segments

      • 8.10.5. Product Portfolio

      • 8.10.6. Business Performance

      • 8.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL ENT ENDOSCOPY MARKET, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL ENT ENDOSCOPY MARKET FOR RIGID ENDOSCOPES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL ENT ENDOSCOPY MARKET FOR FLEXIBLE ENDOSCOPES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL ENT ENDOSCOPY MARKET FOR HEARING SCREENING DEVICES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL ENT ENDOSCOPY MARKET, BY END USER, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL ENT ENDOSCOPY MARKET FOR HOSPITALS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL ENT ENDOSCOPY MARKET FOR AMBULATORY SETTINGS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL ENT ENDOSCOPY MARKET FOR ENT CLINICS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 9. GLOBAL ENT ENDOSCOPY MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 10. NORTH AMERICA ENT ENDOSCOPY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 11. NORTH AMERICA ENT ENDOSCOPY, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 12. NORTH AMERICA ENT ENDOSCOPY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 13. U.S. ENT ENDOSCOPY, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 14. U.S. ENT ENDOSCOPY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 15. CANADA ENT ENDOSCOPY, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 16. CANADA ENT ENDOSCOPY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 17. MEXICO ENT ENDOSCOPY, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 18. MEXICO ENT ENDOSCOPY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 19. EUROPE ENT ENDOSCOPY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 20. EUROPE ENT ENDOSCOPY, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 21. EUROPE ENT ENDOSCOPY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 22. FRANCE ENT ENDOSCOPY, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 23. FRANCE ENT ENDOSCOPY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 24. GERMANY ENT ENDOSCOPY, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 25. GERMANY ENT ENDOSCOPY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 26. ITALY ENT ENDOSCOPY, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 27. ITALY ENT ENDOSCOPY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 28. SPAIN ENT ENDOSCOPY, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 29. SPAIN ENT ENDOSCOPY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 30. UK ENT ENDOSCOPY, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 31. UK ENT ENDOSCOPY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 32. RUSSIA ENT ENDOSCOPY, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 33. RUSSIA ENT ENDOSCOPY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 34. REST OF EUROPE ENT ENDOSCOPY, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 35. REST OF EUROPE ENT ENDOSCOPY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 36. ASIA-PACIFIC ENT ENDOSCOPY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 37. ASIA-PACIFIC ENT ENDOSCOPY, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 38. ASIA-PACIFIC ENT ENDOSCOPY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 39. CHINA ENT ENDOSCOPY, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 40. CHINA ENT ENDOSCOPY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 41. JAPAN ENT ENDOSCOPY, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 42. JAPAN ENT ENDOSCOPY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 43. INDIA ENT ENDOSCOPY, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 44. INDIA ENT ENDOSCOPY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 45. SOUTH KOREA ENT ENDOSCOPY, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 46. SOUTH KOREA ENT ENDOSCOPY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 47. AUSTRALIA ENT ENDOSCOPY, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 48. AUSTRALIA ENT ENDOSCOPY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 49. THAILAND ENT ENDOSCOPY, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 50. THAILAND ENT ENDOSCOPY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 51. MALAYSIA ENT ENDOSCOPY, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 52. MALAYSIA ENT ENDOSCOPY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 53. INDONESIA ENT ENDOSCOPY, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 54. INDONESIA ENT ENDOSCOPY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 55. REST OF ASIA PACIFIC ENT ENDOSCOPY, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 56. REST OF ASIA PACIFIC ENT ENDOSCOPY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 57. LAMEA ENT ENDOSCOPY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 58. LAMEA ENT ENDOSCOPY, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 59. LAMEA ENT ENDOSCOPY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 60. BRAZIL ENT ENDOSCOPY, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 61. BRAZIL ENT ENDOSCOPY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 62. SOUTH AFRICA ENT ENDOSCOPY, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 63. SOUTH AFRICA ENT ENDOSCOPY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 64. SAUDI ARABIA ENT ENDOSCOPY, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 65. SAUDI ARABIA ENT ENDOSCOPY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 66. UAE ENT ENDOSCOPY, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 67. UAE ENT ENDOSCOPY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 68. ARGENTINA ENT ENDOSCOPY, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 69. ARGENTINA ENT ENDOSCOPY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 70. REST OF LAMEA ENT ENDOSCOPY, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 71. REST OF LAMEA ENT ENDOSCOPY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 72. OLYMPUS: KEY EXECUTIVES
  • TABLE 73. OLYMPUS: COMPANY SNAPSHOT
  • TABLE 74. OLYMPUS: OPERATING SEGMENTS
  • TABLE 75. OLYMPUS: PRODUCT PORTFOLIO
  • TABLE 76. OLYMPUS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 77. FUJIFILM: KEY EXECUTIVES
  • TABLE 78. FUJIFILM: COMPANY SNAPSHOT
  • TABLE 79. FUJIFILM: OPERATING SEGMENTS
  • TABLE 80. FUJIFILM: PRODUCT PORTFOLIO
  • TABLE 81. FUJIFILM: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 82. HOYA: KEY EXECUTIVES
  • TABLE 83. HOYA: COMPANY SNAPSHOT
  • TABLE 84. HOYA: OPERATING SEGMENTS
  • TABLE 85. HOYA: PRODUCT PORTFOLIO
  • TABLE 86. HOYA: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 87. KARL STORZ: KEY EXECUTIVES
  • TABLE 88. KARL STORZ: COMPANY SNAPSHOT
  • TABLE 89. KARL STORZ: OPERATING SEGMENTS
  • TABLE 90. KARL STORZ: PRODUCT PORTFOLIO
  • TABLE 91. KARL STORZ: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 92. STRYKER: KEY EXECUTIVES
  • TABLE 93. STRYKER: COMPANY SNAPSHOT
  • TABLE 94. STRYKER: OPERATING SEGMENTS
  • TABLE 95. STRYKER: PRODUCT PORTFOLIO
  • TABLE 96. STRYKER: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 97. ENDOCHOICE: KEY EXECUTIVES
  • TABLE 98. ENDOCHOICE: COMPANY SNAPSHOT
  • TABLE 99. ENDOCHOICE: OPERATING SEGMENTS
  • TABLE 100. ENDOCHOICE: PRODUCT PORTFOLIO
  • TABLE 101. ENDOCHOICE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 102. RICHARD WOLF: KEY EXECUTIVES
  • TABLE 103. RICHARD WOLF: COMPANY SNAPSHOT
  • TABLE 104. RICHARD WOLF: OPERATING SEGMENTS
  • TABLE 105. RICHARD WOLF: PRODUCT PORTFOLIO
  • TABLE 106. RICHARD WOLF: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 107. AOHUA: KEY EXECUTIVES
  • TABLE 108. AOHUA: COMPANY SNAPSHOT
  • TABLE 109. AOHUA: OPERATING SEGMENTS
  • TABLE 110. AOHUA: PRODUCT PORTFOLIO
  • TABLE 111. AOHUA: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 112. JOHNSON AND JOHNSON: KEY EXECUTIVES
  • TABLE 113. JOHNSON AND JOHNSON: COMPANY SNAPSHOT
  • TABLE 114. JOHNSON AND JOHNSON: OPERATING SEGMENTS
  • TABLE 115. JOHNSON AND JOHNSON: PRODUCT PORTFOLIO
  • TABLE 116. JOHNSON AND JOHNSON: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 117. MEDTRONIC PLC.: KEY EXECUTIVES
  • TABLE 118. MEDTRONIC PLC.: COMPANY SNAPSHOT
  • TABLE 119. MEDTRONIC PLC.: OPERATING SEGMENTS
  • TABLE 120. MEDTRONIC PLC.: PRODUCT PORTFOLIO
  • TABLE 121. MEDTRONIC PLC.: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL ENT ENDOSCOPY MARKET SEGMENTATION
  • FIGURE 2. GLOBAL ENT ENDOSCOPY MARKET
  • FIGURE 3. SEGMENTATION ENT ENDOSCOPY MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN ENT ENDOSCOPY MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALENT ENDOSCOPY MARKET
  • FIGURE 11. ENT ENDOSCOPY MARKET SEGMENTATION, BY BY PRODUCT TYPE
  • FIGURE 12. ENT ENDOSCOPY MARKET FOR RIGID ENDOSCOPES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. ENT ENDOSCOPY MARKET FOR FLEXIBLE ENDOSCOPES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. ENT ENDOSCOPY MARKET FOR HEARING SCREENING DEVICES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 15. ENT ENDOSCOPY MARKET SEGMENTATION, BY BY END USER
  • FIGURE 16. ENT ENDOSCOPY MARKET FOR HOSPITALS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 17. ENT ENDOSCOPY MARKET FOR AMBULATORY SETTINGS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 18. ENT ENDOSCOPY MARKET FOR ENT CLINICS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 19. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 20. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 21. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 22. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 23. COMPETITIVE DASHBOARD
  • FIGURE 24. COMPETITIVE HEATMAP: ENT ENDOSCOPY MARKET
  • FIGURE 25. TOP PLAYER POSITIONING, 2024
  • FIGURE 26. OLYMPUS: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 27. OLYMPUS: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 28. OLYMPUS: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 29. FUJIFILM: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 30. FUJIFILM: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 31. FUJIFILM: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 32. HOYA: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 33. HOYA: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 34. HOYA: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 35. KARL STORZ: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 36. KARL STORZ: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 37. KARL STORZ: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 38. STRYKER: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 39. STRYKER: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 40. STRYKER: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 41. ENDOCHOICE: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 42. ENDOCHOICE: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 43. ENDOCHOICE: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 44. RICHARD WOLF: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 45. RICHARD WOLF: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 46. RICHARD WOLF: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 47. AOHUA: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 48. AOHUA: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 49. AOHUA: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 50. JOHNSON AND JOHNSON: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 51. JOHNSON AND JOHNSON: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 52. JOHNSON AND JOHNSON: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 53. MEDTRONIC PLC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 54. MEDTRONIC PLC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 55. MEDTRONIC PLC.: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
ENT endoscopy Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue

© 2025 Allied Market Research. All Rights Reserved